ALLBIOSYN
Latest round
- Angel
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 1
About ALLBIOSYN
ALLBIOSYN, founded in 2023, focuses on developing high-quality raw materials for nucleic acid applications.)???????? specializes in the research and production of nucleotide raw materials. Their core offerings include raw materials for oligonucleotide synthesis, materials for gene sequencing, in vitro diagnostic reagents, mRNA vaccine components, and specialized dyes.The revenue model of ALLBIOSYN is based on direct business-to-business transactions, providing customized nucleic acid raw materials and technical services. This includes partnerships with pharmaceutical companies and research institutions, involving bulk sales of high-purity phosphoramidite monomers and access to technology platforms. The funds will primarily support the R&D and production of key raw materials for nucleic acid drugs, preclinical research, and IND filing for core drugs. The company also plans to enhance its technology platforms, expand its R&D team, and improve laboratory infrastructure, targeting growth in new markets and regions.
Who invested in ALLBIOSYN
1 investor across 1 round
See all investors in ALLBIOSYN
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Sep 24, 2025
Amount
Undisclosed
Investors
Questions about ALLBIOSYN
Who invested in ALLBIOSYN?
ALLBIOSYN has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ALLBIOSYN raised?
ALLBIOSYN has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ALLBIOSYN last raise money?
ALLBIOSYN's most recent round on record is a Angel, in Sep 2025.
What does ALLBIOSYN do?
ALLBIOSYN, founded in 2023, focuses on developing high-quality raw materials for nucleic acid applications.
Where is ALLBIOSYN headquartered?
ALLBIOSYN is headquartered in Shanghai, China.
Which VCs invest in companies like ALLBIOSYN?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ALLBIOSYN's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like ALLBIOSYN? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.